Cittadine Andrew 4
4 · Monopar Therapeutics · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Cittadine Andrew
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-31+1,791→ 42,729 total - Tax Payment
Common Stock
2025-03-31$36.41/sh−744$27,089→ 41,985 total - Exercise/Conversion
Restricted Stock Units
2024-03-31−1,791→ 49,864 total→ Common Stock (1,791 underlying)
Footnotes (4)
- [F1]Represents shares acquired on vesting and settlement of restricted stock units.
- [F2]Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
- [F3]On February 2, 2022, the reporting person was granted 13,000 restricted stock units, vesting 6/48ths (1,625 shares) on June 30, 2022, and 3/48ths (813 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- [F4]On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.